BlackRock Health Sciences Trust (NYSE:BME) Holdings Decreased by Wells Fargo & Company MN

featured-image

Wells Fargo & Company MN lowered its stake in BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 20.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 338,971 shares of the company’s stock after selling 88,977 shares during the quarter. Wells Fargo [...]

Wells Fargo & Company MN lowered its stake in BlackRock Health Sciences Trust ( NYSE:BME – Free Report ) by 20.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 338,971 shares of the company’s stock after selling 88,977 shares during the quarter.

Wells Fargo & Company MN’s holdings in BlackRock Health Sciences Trust were worth $12,857,000 at the end of the most recent quarter. Other institutional investors and hedge funds have also recently bought and sold shares of the company. HBK Sorce Advisory LLC lifted its stake in shares of BlackRock Health Sciences Trust by 14.



8% in the 4th quarter. HBK Sorce Advisory LLC now owns 8,194 shares of the company’s stock worth $311,000 after acquiring an additional 1,057 shares during the period. Hara Capital LLC bought a new stake in BlackRock Health Sciences Trust during the fourth quarter worth approximately $832,000.

AlphaStar Capital Management LLC acquired a new stake in BlackRock Health Sciences Trust in the fourth quarter worth approximately $878,000. Janney Montgomery Scott LLC boosted its stake in BlackRock Health Sciences Trust by 40.5% during the 4th quarter.

Janney Montgomery Scott LLC now owns 32,787 shares of the company’s stock valued at $1,244,000 after purchasing an additional 9,455 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new position in BlackRock Health Sciences Trust during the 4th quarter valued at $3,250,000.

BlackRock Health Sciences Trust Price Performance BME opened at $36.13 on Wednesday. The stock’s fifty day moving average is $38.

76 and its 200-day moving average is $39.47. BlackRock Health Sciences Trust has a one year low of $34.

18 and a one year high of $42.64. BlackRock Health Sciences Trust Dividend Announcement BlackRock Health Sciences Trust Company Profile ( Free Report ) BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC.

It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. Featured Articles Want to see what other hedge funds are holding BME? Visit HoldingsChannel.

com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust ( NYSE:BME – Free Report ). Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter .

.